Trial intelligence / Profile preview

Melatonin for Sleep in Heart Failure Patients

NCT00869869Phase 2Withdrawn

Sponsor
Brigham and Women's Hospital
Start
Mar 2009
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of melatonin in sleep disorder, sponsored by Brigham and Women's Hospital. Planned start Mar 2009; status: withdrawn.

02

Drugs

melatonin
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT00869869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00869869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call